A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

Recruiting now · Phase 1

Conditions studied: Primary Hypercholesterolaemia

In brief

Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.

Key facts

Study ID

NCT06884098

Run by

Addpharma Inc.

People needed

60

Starts

2025-03-10

Expected to finish

2025-04-01

Last updated by the study team

2025-03-20

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
• The Age equal to or greater than 19 in healthy volunteers at the time of screening visit

You may not qualify if…

• Participation in other clinical study with an investigational drug within the 6 months from scheduled first administration
• Other exclusions applied

Where it is running

• H Plus Yangji Hospital — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.